These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35965904)
1. A Randomized Comparative Study of Intralesional Tranexemic Acid and Kligman's Regimen in Indian Patients with Melasma. Gupta P; Poojary S; Dubey L J Cutan Aesthet Surg; 2022; 15(2):135-141. PubMed ID: 35965904 [TBL] [Abstract][Full Text] [Related]
2. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma. Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962 [TBL] [Abstract][Full Text] [Related]
3. A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma. Nasimi M; Ghiasi M; Lajevardi V; Nasiri F; Shakoei S Arch Dermatol Res; 2022 Oct; 314(8):791-797. PubMed ID: 34705101 [TBL] [Abstract][Full Text] [Related]
4. A Randomized Study to Evaluate the Efficacy of Oral Tranexamic Acid, Modified Kligman's Formula, and Placebo Cream in Melasma. Prathyoosha S; Ananditha K; Narayana Rao T; Gopal KVT; Krishnam Raju PV Indian Dermatol Online J; 2024; 15(5):787-793. PubMed ID: 39359301 [TBL] [Abstract][Full Text] [Related]
5. Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma. Eshghi G; Khezrian L; Esna Ashari F Acta Med Iran; 2016 Jan; 54(1):67-71. PubMed ID: 26853293 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: A randomized, double-blind clinical trial study. Karrabi M; David J; Sahebkar M Skin Res Technol; 2021 Jan; 27(1):24-31. PubMed ID: 32585079 [TBL] [Abstract][Full Text] [Related]
7. Comparative Study of Combination of Oral Tranexamic Acid With Modified Kligman's Formula Versus Oral Tranexamic Acid With Azelaic Acid 15% in the Treatment of Melasma. Singh R; Maheshwari P; Madke B; Singh A; Jawade S Cureus; 2023 Jun; 15(6):e40908. PubMed ID: 37496546 [TBL] [Abstract][Full Text] [Related]
8. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Sarkar R; Kaur C; Bhalla M; Kanwar AJ Dermatol Surg; 2002 Sep; 28(9):828-32; discussion 832. PubMed ID: 12269877 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study. AboAlsoud ES; Eldahshan RM; AbouKhodair Mohammed H; Elsaie ML J Cosmet Dermatol; 2022 Jun; 21(6):2508-2515. PubMed ID: 35357753 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intralesional steroid injection in the treatment of melasma. Nassar AAE; Ibrahim AM; Mahmoud AA J Cosmet Dermatol; 2021 Mar; 20(3):862-867. PubMed ID: 32741075 [TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma. Patil NK; Bubna AK Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158 [TBL] [Abstract][Full Text] [Related]
12. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study. Abd Elraouf IG; Obaid ZM; Fouda I Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856 [TBL] [Abstract][Full Text] [Related]
13. Cysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action. Sachdev M; Grimes PE; Callender V; Hartman CL; Taylor SC; Elbuluk N; Badawi A; Funasaka Y; Lim J; Ng CY; Desai SR J Drugs Dermatol; 2024 Feb; 23(2):9-16. PubMed ID: 38306138 [TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial. Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390 [TBL] [Abstract][Full Text] [Related]
15. A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment. Sardesai VR; Kolte JN; Srinivas BN Indian J Dermatol; 2013 May; 58(3):239. PubMed ID: 23723484 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study. Minni K; Poojary S J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2636-2644. PubMed ID: 32567734 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial. Bertold C; Fontas E; Singh T; Gastaut N; Ruitort S; Wehrlen Pugliese S; Passeron T J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2601-2607. PubMed ID: 37620285 [TBL] [Abstract][Full Text] [Related]
18. Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula. Kasraee B; Mansouri P; Farshi S J Cosmet Dermatol; 2019 Feb; 18(1):293-295. PubMed ID: 30537063 [TBL] [Abstract][Full Text] [Related]
19. A Pilot Study to Compare Therapeutic Efficacy and Safety of Combined Treatment of Skin Microneedling and Depigmenting Cream versus Depigmenting Cream Alone in Facial Melasma at Tertiary Care Center. Bosamiya SS; Jain SM J Cutan Aesthet Surg; 2021; 14(2):156-159. PubMed ID: 34566356 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficiency and safety assessment of intradermal platelet-rich plasma combined with oral tranexamic acid in patients with facial melasma. Tawanwongsri W; Siri-Archawawat D; Sindhusen S; Eden C Adv Clin Exp Med; 2024 Jun; ():. PubMed ID: 38934336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]